Logout
 CME Information
 Editorial Board
 Lessons by Volume
   Volume 22
   Volume 21
   Volume 20
   Volume 19
   Volume 18
   Volume 17
   Volume 16
   Volume 15
 
 

COPD in the Never-Smoker

By David M. Mannino, MD, FCCP; and Kathryn Marie McGonigle

Print This | TOC | Previous | Next

References

  1. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease: American Thoracic Society. Am J Respir Crit Care Med 1995; 152(5 pt 2):S77--S121
  2. Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD): The European Respiratory Society Task Force. Eur Respir J 1995; 8:1398-1420
  3. World Health Organization. The GOLD global strategy for the management and prevention of COPD. Available at http://www.goldcopd.com. Accessed February 26, 2003
  4. Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary disease surveillanceÑUnited States, 1971-2000. MMWR Surveill Summ 2002; 51(6):1-16
  5. Mannino DM, Gagnon RC, Petty TL, et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000; 160:1683-1689
  6. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest 2000; 117(2 suppl):5S-9S
  7. Michaud CM, Murray CJ, Bloom BR. Burden of disease: implications for future research. JAMA 2001; 285:535-539
  8. Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med 1998; 4:1241-1243
  9. Silverman EK, Speizer FE. Risk factors for the development of chronic obstructive pulmonary disease. Med Clin North Am 1996; 80:501-522
  10. Meyer PA, Mannino DM, Redd SC, et al. Characteristics of adults dying with chronic obstructive pulmonary disease. Chest 2002; 122:2003-2008
  11. OÕByrne PM, Postma DS. The many faces of airway inflammation: asthma and chronic obstructive pulmonary disease; Asthma Research Group. Am J Respir Crit Care Med 1999; 159(5 pt 2):S41-S63
  12. Sparrow D, OÕConnor G, Weiss ST. The relation of airways responsiveness and atopy to the development of chronic obstructive lung disease. Epidemiol Rev 1988; 10:29-47
  13. Hendrick DJ. Occupational and chronic obstructive pulmonary disease (COPD). Thorax 1996; 51:947-955
  14. Abbey DE, Burchette RJ, Knutsen SF, et al. Long-term particulate and other air pollutants and lung function in nonsmokers. Am J Respir Crit Care Med 1998; 158:289-298
  15. Silverman EK, Weiss ST, Drazen JM, et al. Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162:2152-2158
  16. Chen Y, Dales R, Krewski D, et al. Increased effects of smoking and obesity on asthma among female Canadians: the National Population Health Survey, 1994-1995. Am J Epidemiol 1999; 150:255-262
  17. Bakke PS, Hanoa R, Gulsvik A. Educational level and obstructive lung disease given smoking habits and occupational airborne exposure: a Norwegian community study. Am J Epidemiol 1995; 141:1080-1088
  18. Hu G, Cassano PA. Antioxidant nutrients and pulmonary function: the Third National Health and Nutrition Examination Survey (NHANES III). Am J Epidemiol 2000; 151:975-981
  19. Britton J, Martinez FD. The relationship of childhood respiratory infection to growth and decline in lung function. Am J Respir Crit Care Med 1996; 154(6 pt 2): S240-S245.
  20. Ulrik CS, Backer V. Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma. Eur Respir J 1999; 14:892-896
  21. Burrows B. The course and prognosis of different types of chronic airflow limitation in a general population sample from Arizona: comparison with the Chicago ÒCOPDÓ series. Am Rev Respir Dis 1989; 140:S92-S94
  22. Ramsdale EH, Morris MM, Roberts RS, et al. Bronchial responsiveness to methacholine in chronic bronchitis: relationship to airflow obstruction and cold air responsiveness. Thorax 1984; 39:912-918
  23. Mayer AS, Newman LS. Genetic and environmental modulation of chronic obstructive pulmonary disease. Respir Physiol 2001; 128:3-11
  24. Zevin S, Benowitz NL. Drug interactions with tobacco smoking: an update. Clin Pharmacokinet 1999; 36:425-438
  25. Lomas DA, Silverman EK. The genetics of chronic obstructive pulmonary disease. Respir Res 2001; 2(1):20-26
  26. Hall IP. Genetics and pulmonary medicine 8: asthma. Thorax 1999; 54:65-69
  27. Soriano JB, Maier WC, Egger P, et al. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax 2000; 55:789-794
  28. Chen Y, Breithaupt K, Muhajarine N. Occurrence of chronic obstructive pulmonary disease among Canadians and sex-related risk factors. J Clin Epidemiol 2000; 53:755-761
  29. Dennis RJ, Maldonado D, Norman S et al. Wood smoke exposure and risk for obstructive airways disease among women. Chest 1996; 109(3 suppl):55S-56S
  30. Sherrill DL, Lebowitz MD, Knudson RJ, et al. Smoking and symptom effects on the curves of lung function growth and decline. Am Rev Respir Dis 1991; 144:17-22
  31. Lange P, Ulrik CS, Vestbo J. Mortality in adults with self-reported asthma: Copenhagen City Heart Study Group. Lancet 1996; 347:1285-1289
  32. Rabatin JT, Cowl CT. A guide to the diagnosis and treatment of occupational asthma. Mayo Clin Proc 2001; 76:633-640
  33. Vedal S, Enarson DA, Chan H, et al. A longitudinal study of the occurrence of bronchial hyperresponsiveness in western red cedar workers. Am Rev Respir Dis 1988; 137:651-655
  34. Vedal S, Enarson DA, Chan-Yeung M. Airway size and the rate of pulmonary function decline in grain handlers. Am Rev Respir Dis 1988; 138:1584-1588
  35. Malo JL, Ghezzo H, DÕAquino C, et al. Natural history of occupational asthma: relevance of type of agent and other factors in the rate of development of symptoms in affected subjects. J Allergy Clin Immunol 1992; 90:937-944
  36. Davison AG, Fayers PM, Taylor AJ, et al. Cadmium fume inhalation and emphysema. Lancet 1988; 1(8587):663-667
  37. From the Centers for Disease Control and Prevention: fixed obstructive lung disease in workers at a microwave popcorn factoryÑMissouri, 2000-2002. JAMA 2002; 287:2939-2940
  38. Alberts WM, Brooks SM. Reactive airways dysfunction syndrome. Curr Opin Pulm Med 1996; 2(2):104-110
  39. Coultas DB. Health effects of passive smoking: 8. Passive smoking and risk of adult asthma and COPD; an update. Thorax 1998; 53:381-387
  40. Piitulainen E, Tornling G, Eriksson S. Environmental correlates of impaired lung function in non-smokers with severe alpha 1-antitrypsin deficiency (PiZZ). Thorax 1998; 53:939-943
  41. Stick S. Pediatric origins of adult lung disease: 1. The contribution of airway development to paediatric and adult lung disease. Thorax 2000; 55:587-594
  42. Wilson R. The role of infection in COPD. Chest 1998; 113(4 suppl):242S-248S
  43. Hogg JC. Viral infection and exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164:1555-1556
  44. Walda IC, Tabak C, Smit HA, et al. Diet and 20-year chronic obstructive pulmonary disease mortality in middle-aged men from three European countries. Eur J Clin Nutr 2002; 56:638-643
  45. Pela R, Calcagni AM, Subiaco S, et al. N-acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPD. Respiration 1999; 66:495-500
  46. Massaro GD, Massaro D. Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats. Nat Med 1997; 3:675-677
  47. Schwartz J, Weiss ST. The relationship of dietary fish intake to level of pulmonary function in the first National Health and Nutrition Survey (NHANES I). Eur Respir J 1994; 7:1821-1824
  48. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000; 343:269-280

Copyright ©2003 American College of Chest Physicians

Print This | TOC | Previous | Next

 
 

3300 Dundee Road • Northbrook, Illinois 60062-2348 • (847) 498-1400 • (800) 343-2227
Copyright ©1999-2008 American College of Chest Physicians. All Rights Reserved.
ACCP Privacy Policy | ACCP Web Site Terms of Use